Skip to content

The effect of Anahil 500 (bromelain 500) and vitamin C on episiotomy wound healing

The effect of Anahil 500 (bromelain 500) and vitamin C on episiotomy wound healing in primiparous women

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20160523028008N25
Enrollment
140
Registered
2022-08-16
Start date
2022-08-23
Completion date
Unknown
Last updated
2022-08-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Episiotomy. Complications of the puerperium, not elsewhere classified

Interventions

Intervention 1: Intervention group: bromelain 500mg (one tablet) (Salamat Permon Amin) 2 hours after delivery three times a day along with oral vitamin C 100mg one tablet (Elixir Pharmaceuticals) fo

Sponsors

Hamedan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: Age between 18 to 40 years Gestational age between 37 to 42 weeks single pregnancy cephalic presentation Normal vaginal delivery newborn Weight between 2500 to 4000 grams Medio-lateral episiotomy with 4-3 cm lengt Education level at least the fifth grade, body mass index: 19.8-26 kg/m2 Cervical dilation 3-5 cm

Exclusion criteria

Exclusion criteria: Diseases affecting wound healing Smoking and drug abuse Consumption of drugs affecting wound healing (glucocorticoids, anti-coagulatives, immune system suppressants, antibiotics or chemotherapy agents) abortion premature rupture of membranes having symptoms indicative of infection Anemia abnormal first, second or third delivery stage dead baby

Design outcomes

Primary

MeasureTime frame
Pain. Timepoint: 2 hrs after delivery, 24 hrs after delivery, 1 hr after consumption of initial dose. Method of measurement: VAS scale.;Wound healing. Timepoint: 3th, 7th, and 14th day after deliver. Method of measurement: REEDA scale.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactShahla Nasrolahi

Hamedan University of Medical Sciences

Dr-nasrolahi@yahoo.com+98 81 3838 0717

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026